Autor: |
Dasgupta T; Department of Women & Children's Health, School of Life Course & Population Sciences, King's College London, London SE1 1UL, UK., Boulding H; The Policy Institute, Faculty of Social Science & Public Policy, King's College London, London WC2B 6LE, UK., Easter A; Department of Women & Children's Health, School of Life Course & Population Sciences, King's College London, London SE1 1UL, UK., Sutedja T; The RESILIENT Study Patient & Public Involvement & Engagement Advisory Group, UK., Khalil A; Fetal Medicine Unit, St. George's University Hospitals NHS Foundation Trust, London SW17 0QT, UK.; Fetal Medicine Unit, Liverpool Women's NHS Foundation Trust, Liverpool L8 7SS, UK., Mistry HD; Department of Women & Children's Health, School of Life Course & Population Sciences, King's College London, London SE1 1UL, UK., Horgan G; Department of Women & Children's Health, School of Life Course & Population Sciences, King's College London, London SE1 1UL, UK., Van Citters AD; The Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine, Dartmouth College, Hanover, NH 03756, USA., Nelson EC; The Dartmouth Institute for Health Policy & Clinical Practice, Geisel School of Medicine, Dartmouth College, Hanover, NH 03756, USA., von Dadelszen P; Department of Women & Children's Health, School of Life Course & Population Sciences, King's College London, London SE1 1UL, UK., Duncan EL; Department of Twin Research & Genetic Epidemiology, School of Life Course & Population Sciences, King's College London, London SE1 7EH, UK., The Resilient Study Group; The RESILIENT Study Group, UK., Silverio SA; Department of Women & Children's Health, School of Life Course & Population Sciences, King's College London, London SE1 1UL, UK.; Department of Psychology, Institute of Population Health, University of Liverpool, Liverpool L69 7ZA, UK., Magee LA; Department of Women & Children's Health, School of Life Course & Population Sciences, King's College London, London SE1 1UL, UK. |
Abstrakt: |
Maternal vaccination during pregnancy, in general and against COVID-19 infection, offers protection to both mother and baby, but uptake remains suboptimal. This study aimed to explore the perceptions regarding COVID-19 vaccination in pregnancy, particularly for marginalised populations and those living with social or medical complexity. A total of 96 semi-structured in-depth interviews were conducted with 40 women, 15 partners, 21 HCPs, and 20 policy makers, across all four nations of the United Kingdom (UK), discussing their lived experience of utilising, delivering, or developing policy for COVID-19 vaccination in pregnancy during the pandemic. Three themes were derived: (1) historical and social context, (2) communication of information and guidance, and (3) appraisal and action. Together these captured the participants' legacy of mistrust in drugs during pregnancy; prior positive experiences; concerns about missing information, conflicting information, or false information about COVID-19 vaccines; and confusing guidance for pregnant women. The final theme describes the participants' behaviour and actions undertaken consequent to their experiences and the available information. The findings suggest efforts to improve COVID-19 vaccination in pregnancy may be best focused on personalised communication of information. A trusting relationship and prior positive experiences with other vaccines, both in and outside of pregnancy, positively influenced perceptions of COVID-19 vaccination. |